V
Vladimir Khatskelevich Khavinson
Publications - 18
Citations - 131
Vladimir Khatskelevich Khavinson is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 5, co-authored 12 publications receiving 122 citations.
Papers
More filters
Patent
Pharmaceutical dipeptide compositions and methods of use thereof
TL;DR: In this paper, methods for the therapy of immunodeficient, immunodepressed or hyperactive immune states and for the prevention and treatment of opportunistic infections in such states comprising administering to a subject a pharmaceutically acceptable composition comprising as an active ingredient the dipeptide L-Ile-L-Trp, linear and cyclic monomers and polymers thereof.
Patent
Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
Vladimir Khatskelevich Khavinson,Morozov Vyacheslav G,Sergy Vladimirovich Sery,Lawrence R. Green,Nicolay V. Sinackevich,Andrei L. Kozhemyakin +5 more
TL;DR: In this article, the authors present compositions and methods for treatment of a variety of disease states, such as infections, hyper immune states, immunodeficiencies, and the like.
Patent
Pharmaceutical preparation for treating immunodeficiency conditions
German Mikhailovich Yakovlev,Vyacheslav G. Morozov,Vladimir Khatskelevich Khavinson,V. I. Deigin,Andrei Marxovich Korotkov +4 more
TL;DR: A pharmaceutical preparation for treating immunodeficiency conditions consists of an active substance-peptide having the structure H-L-Glu-Ltaurp-OH, and of a pharmaceutical diluent.
Patent
Pharmaceutical preparation for the therapy of immune deficiency conditions
TL;DR: A peptide of the structure: H-L-Glu-L -Trp-OH and a pharmaceutically acceptable vehicle for the therapy of immune deficiency conditions is described in this paper.
Patent
Use of a dipeptide for stimulating repair processes
Vladimir Khatskelevich Khavinson,Morozov Vyacheslav G,Vladimir Viktorovich Malinin,Sergei Vladimirovich Sery +3 more
TL;DR: In this article, a pharmaceutical peptide preparation capable of stimulating regeneration consists of pharmaceutically admissible carrier and effective quantity of dipeptides as an active part, which is a combination of: L-lysil-L-gluthmine acid or its salts.